Please assess the completion status of the following clinical trial:

Trial Title: Iron Deficiency (ID) in Infants

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Infants aged 22-26 months~* living usually in France~* written agreement of one parent or the holder of parental authority~* followed-up by a liberal paediatrician~* with social coverage~Exclusion Criteria:~* chronic disease known at inclusion that might affect iron metabolism or reserves : blood transfusion since birth, celiac disease, chronic inflammatory disease, including of the intestines, cystic fibrosis, other enteropathy, enteral nutrition for more than 15 days in the past 6 months, chronic hemolytic diseases, chronic kidney disease, hemophilia, or chronic bleeding, such as ENT or gastrointestinal, hemochromatosis, any malignant condition, or lead poisoning)~* participation to another study

- Gender: ALL
- Minimum Age: 22 Months
- Maximum Age: 26 Months
- Healthy Volunteers: f

Study Arms:
- infants followed by pediatrician (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).